Common heart drug may slow progression of Huntington's disease
- Details
- Category: Research
Using clinical information from a large, observational database of over 21,000 people with HD, the UI team found that the use of beta-blocker drugs - commonly used to treat heart and blood pressure issues - was associated with both a significantly later onset of HD symptoms for people in the pre-symptomatic stages, and a slower rate of symptom worsening for those with symptoms.
NIH-developed AI algorithm successfully matches potential volunteers to clinical trials release
- Details
- Category: Research
AI can predict study results better than human experts
- Details
- Category: Research
The findings, published in Nature Human Behaviour, demonstrate that large language models (LLMs) trained on vast datasets of text can distil patterns from scientific literature, enabling them to forecast scientific outcomes with superhuman accuracy.
First new treatment for asthma attacks in 50 years
- Details
- Category: Research
The findings, published today in The Lancet Respiratory Medicine, could be "game-changing" for millions of people with asthma and COPD around the world, scientists say.
Pfizer announces new Chief Scientific Officer and President, Research & Development
- Details
- Category: Pfizer
Phages, towards a targeted alternative to antibiotics
- Details
- Category: Research
New hope for diabetic heart disease treatment
- Details
- Category: Research
Heart conditions like atherosclerosis, heart attacks and heart failure are the leading killers of people with diabetes, driving a growing global health crisis.
First molecule identified that promotes gut healing while inhibiting tumour progression
- Details
- Category: Research
Many patients with inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis do not respond to available treatments, highlighting the need to identify novel therapeutic strategies.
Stopping severe malaria by harnessing natural human antibodies
- Details
- Category: Research
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
- Details
- Category: AstraZeneca